CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (221,273)	$ 39,241
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	1,345	1,866
Foreign currency transaction gains	(13,069)	(29,964)
Changes in operating assets and liabilities:
Research supplies	9,210	3,191
Grant funds receivable	2,744	(27,484)
Development Agreement receivables	0	5,905
Prepaid expenses and other current assets	9,286	19,981
Accounts payable and accrued liabilities	(16,639)	(54,800)
Deferred revenues	0	(81,385)
Other liabilities	(45)	4,110
NET CASH USED IN OPERATING ACTIVITIES	(228,441)	(119,339)
CASH FLOWS FROM INVESTING ACTIVITIES
NET CASH USED IN INVESTING ACTIVITIES	0	0
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock	40,000	40,000
Cash received for issuance of preferred stock	201,800	60,090
Proceeds from related party loan	0	61,434
Repayment of related party loan	0	(58,172)
NET CASH PROVIDED BY FINANCING ACTIVITIES	241,800	103,352
EFFECT OF FOREIGN CURRENCY EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(2,948)	(8,796)
NET DECREASE IN CASH AND CASH EQUIVALENTS	10,411	(24,783)
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR	89,132	113,915
CASH AND CASH EQUIVALENTS - END OF YEAR	$ 99,543	$ 89,132